Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.5/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnlyHint=true, openWorldHint=true, idempotentHint=true, and destructiveHint=false, covering safety and idempotency. The description adds valuable behavioral context: data sources (SEC EDGAR for companies, FAERS for drugs), sorting by primary metric, and citation URI returns.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is moderately concise and well-structured, starting with trigger phrases followed by usage guidance and type-specific details. Every sentence adds value, though it could be slightly streamlined without losing clarity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite the lack of an output schema, the description adequately explains return format (paired data with citation URIs) and sorting behavior. The tool's purpose is well-covered, and the context signals show low complexity (2 params, no nested objects).

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema covers both parameters (type and values) with 100% description coverage. The description enriches the schema by explaining the difference between company and drug types, providing examples for values, and specifying constraints (2-5 items).

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparisons of 2-5 companies or drugs, using specific trigger phrases like 'Compare X and Y' and 'X vs Y'. It distinguishes itself from sibling tools by explicitly preferring this over sequential single-pack lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit guidance on when to use this tool: 'ALWAYS PREFER over sequential single-pack lookups when comparing entities.' It also differentiates between company and drug types with concrete examples, giving agents clear context for invocation.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Multiple tool clusters have overlapping functions: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are nearly interchangeable, deep_research overlaps with the ask_pipeworx family, and the six Polymarket tools all analyze the same domain with subtle differences. discover_tools and suggest_questions also both serve as discovery entry points, making it difficult for an agent to confidently select the correct tool.

Naming Consistency3/5

All names are snake_case, but there is no uniform structural pattern. Verb_object names like format_currency and resolve_entity coexist with noun_phrases like entity_profile and polymarket_arbitrage, bare verbs like remember and forget, and adjective_noun forms like recent_alerts. Cluster-specific prefixes are consistent, but the overall convention is mixed.

Tool Count2/5

With 33 tools, the set is substantially over-scoped and exceeds the suggested 3-15 range. Many tools could be consolidated, such as the three ask_pipeworx variants, the six Polymarket tools, and the two formatting utilities. The broad domain justifies some size, but the count feels inflated and will burden agents with excessive choice.

Completeness3/5

The server covers many areas thoroughly: memory has remember/recall/forget, subscriptions have subscribe/unsubscribe/list/recent_alerts, and research tools span lookup, profiling, comparison, and verification. However, there are notable gaps: pipeworx:// citation URIs are returned but no tool explicitly fetches or reads a record by URI, and there is no direct way to manage account-level settings beyond memory. These missing operations force agents to work around limitations.